US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jul 24, 2015 (11 years ago)

univasc

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Testing: Failed 24 month dissolution testing.

What was recalled

univasc (moexipril HCl) tablets, 7.5 mg, 100 Ct Bottle, Rx Only. Manufactured for UCB, Inc., Smyrna, GA 30080. NDC: 0091-3707-01.

Recalling firm
Ucb, Inc
Origin
GA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1348-2015

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Moexipril recalls

See all
Class II · Moderate risk Terminated

Moexipril Hydrochloride and Hydrocholorothiazide Tablets USP

Reason Failed Impurities/Degradation Specifications: High out of specification test result for the Moexipril Diketopiperazine impurity was obtained during routine stability testing.

Teva Pharmaceuticals USA NDC 0093-5213-01 D-0208-2018
Class II · Moderate risk Terminated

Moexipril HCl Tablets 7.5mg

Reason Paddock Laboratories, LLC are recalling one lot (2012028142) of Moexipril HCl Tablets 7.5mg (expiration 1/2014) because of a non-conformity dissolution failure result found during routine stability testing at the 6 month test interval.

Paddock Laboratories, LLC NDC 0574-0110-01 D-007-2013